Biological determinants of long-term survival in chronic myelogenous leukemia patients treated with conventional chemotherapy

Acta Haematol. 1997;97(3):187-8. doi: 10.1159/000203679.

Authors

P Foa¹, A Iurlo, A Orazi, G Saglio, S Ribera, F Bertoni, S Caldiera, M Fornier, A T Maiolo

Affiliation

¹ Istituto di Scienze Mediche, Università degli Studi, Milano, Italia.

PMID: 9066716
DOI: 10.1159/000203679

No abstract available

MeSH terms

Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / physiopathology*
Male
Middle Aged